
Elías Campo
Director de la FRCB-IDIBAPSGrup de recerca
- Patologia molecular en neoplàsies limfoides Group leader (R4)
Sobre mi
Elias Campo es Catedràtic d ’Anatomia Patologica i Consultor Senior a l’Hospital Clínic, Universitat de Barcelona. La seva recerca es centra en la caracterització molecular de neoplàsies limfoides. En els últims anys el seu treball tracta d’elucidar les alteracions genòmiques i funcionals de la leucèmia limfàtica crònica, limfoma de cèl·lules del mantell i altres limfomes agressius i el seu impacte en entendre la seva patogènesis i el maneig dels pacients. Ha estat Co-Director del projecte Espanyol del genoma de la leucèmia limfàtica crònica en el International Cancer Genome Consortium . Es membre de la USA National Academy of Medicine des de 2018.
Publicacions destacades
-
The International Consensus Classification of Mature Lymphoid Neoplasms: A Report from the Clinical Advisory Committee
Autors: Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC, Brousset P, Cerroni L, de Leval L, Dirnhofer S, Dogan A, Feldman AL, Fend F, Friedberg JW, Gaulard P, Ghia P, Horwitz SM, King RL, Salles G, San-Miguel J, Seymour JF, Treon SP, Vose JM, Zucca E, Advani R, Ansell S, Au WY, Barrionuevo C, Bergsagel L, Chan WC, Cohen JI, d'Amore F, Davies A, Falini B, Ghobrial IM, Goodlad JR, Gribben JG, Hsi ED, Kahl BS, Kim WS, Kumar S, LaCasce AS, Laurent C, Lenz G, Leonard JP, Link MP, Lopez-Guillermo A, Mateos MV, Macintyre E, Melnick AM, Morschhauser F, Nakamura S, Narbaitz M, Pavlovsky A, Pileri SA, Piris M, Pro B, Rajkumar V, Rosen ST, Sander B, Sehn L, Shipp MA, Smith SM, Staudt LM, Thieblemont C, Tousseyn T, Wilson WH, Yoshino T, Zinzani PL, Dreyling M, Scott DW, Winter JN, Zelenetz AD .Referència: Blood 2022. -
Molecular map of chronic lymphocytic leukemia and its impact on outcome
Autors: Knisbacher BA, Lin Z, Hahn CK, Nadeu F, Duran-Ferrer M, Stevenson KE, Tausch E, Delgado J, Barbera-Mourelle A, Taylor-Weiner A, Bousquets-Muñoz P, Diaz-Navarro A, Dunford A, Anand S, Kretzmer H, Gutierrez-Abril J, López-Tamargo S, Fernandes SM, Sun C, Sivina M, Rassenti LZ, Schneider C, Li S, Parida L, Meissner A, Aguet F, Burger JA, Wiestner A, Kipps TJ, Brown JR, Hallek M, Stewart C, Neuberg DS, Martín-Subero JI, Puente XS, Stilgenbauer S, Wu CJ, Campo E, Getz G .Referència: Nature Genetics 2022. -
Detection of early seeding of Richter transformation in chronic lymphocytic leukemia
Autors: Nadeu F, Royo R, Massoni-Badosa R, Playa-Albinyana H, Garcia-Torre B, Duran-Ferrer M, Dawson KJ, Kulis M, Diaz-Navarro A, Villamor N, Melero JL, Chapaprieta V, Dueso-Barroso A, Delgado J, Moia R, Ruiz-Gil S, Marchese D, Giró A, Verdaguer-Dot N, Romo M, Clot G, Rozman M, Frigola G, Rivas-Delgado A, Baumann T, Alcoceba M, González M, Climent F, Abrisqueta P, Castellví J, Bosch F, Aymerich M, Enjuanes A, Ruiz-Gaspà S, López-Guillermo A, Jares P, Beà S, Capella-Gutierrez S, Gelpí JL, López-Bigas N, Torrents D, Campbell PJ, Gut I, Rossi D, Gaidano G, Puente XS, Garcia-Roves PM, Colomer D, Heyn H, Maura F, Martín-Subero JI, Campo E .Referència: Nature Medicine 2022. -
IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics
Autors: Nadeu F, Royo R, Clot G, Duran-Ferrer M, Navarro A, Martín S, Lu J, Zenz T, Baumann T, Jares P, Puente XS, Martín-Subero JI, Delgado J, Campo E .Referència: Blood 2021. -
Genomic and epigenomic insights into the origin, pathogenesis and clinical behavior of mantle cell lymphoma subtypes
Autors: Nadeu F, Martin-Garcia D, Clot G, Díaz-Navarro A, Duran-Ferrer M, Navarro A, Vilarrasa-Blasi R, Kulis M, Royo R, Gutiérrez-Abril J, Valdés-Mas R, López C, Chapaprieta V, Puiggros M, Castellano G, Costa D, Aymerich M, Jares P, Espinet B, Muntañola A, Ribera-Cortada I, Siebert R, Colomer D, Torrents D, Gine E, López-Guillermo A, Küppers R, Martin-Subero JI, Puente XS, Beà S, Campo E .Referència: Blood 2020. -
IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasms
Autors: Nadeu, F; Mas-de-les-Valls, R; Navarro, A; Royo, R; Martin, S; Villamor, N; Suarez-Cisneros, H; Mares, R; Lu, JY; Enjuanes, A; Rivas-Delgado, A; Aymerich, M; Baumann, T; Colomer, D; Delgado, J; Morin, RD; Zenz, T; Puente, XS; Campbell, PJ; Bea, S; Maura, F; Campo, E.Referència: Nature Communications 2020. -
CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1- mantle cell lymphoma
Autors: Martín-Garcia D, Navarro A, Valdés-Mas R, Clot G, Gutiérrez-Abril J, Prieto M, Ribera-Cortada I, Woroniecka R, Rymkiewicz G, Bens S, de Leval L, Rosenwald A, Ferry JA, Hsi ED, Fu K, Delabie J, Weisenburger D, de Jong D, Climent F, O'Connor SJ, Swerdlow SH, Torrents D, Beltran S, Espinet B, González-Farré B, Veloza L, Costa D, Matutes E, Siebert R, Ott G, Quintanilla-Martinez L, Jaffe ES, López-Otín C, Salaverria I, Puente XS, Campo E, Beà S .Referència: Blood 2019. -
A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome
Autors: Clot, Guillem; Jares, Pedro; Gine, Eva; Navarro, Alba; Royo, Cristina; Pinyol, Magda; Martin-Garcia, David; Demajo, Santiago; Espinet, Blanca; Salar, Antonio; Ferrer, Ana; Muntanola, Ana; Aymerich, Marta; Rauert-Wunderlich, Hilka; Jaffe, Elaine S.; Connors, Joseph M.; Gascoyne, Randy D.; Delabie, Jan; Lopez-Guillermo, Armando; Ott, German; Wright, George W.; Staudt, Louis M.; Rosenwald, Andreas; Scott, David W.; Rimsza, Lisa M.; Bea, Silvia; Campo, Elias;.Referència: Blood 2018. -
Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets
Autors: Karube, K.; Enjuanes, A.; Dlouhy, I.; Jares, P.; Martin-Garcia, D.; Nadeu, F.; Ordonez, G. R.; Rovira, J.; Clot, G.; Royo, C.; Navarro, A.; Gonzalez-Farre, B.; Vaghefi, A.; Castellano, G.; Rubio-Perez, C.; Tamborero, D.; Briones, J.; Salar, A.; Sancho, J. M.; Mercadal, S.; Gonzalez-Barca, E.; Escoda, L.; Miyoshi, H.; Ohshima, K.; Miyawaki, K.; Kato, K.; Akashi, K.; Mozos, A.; Colomo, L.; Alcoceba, M.; Valera, A.; Carrio, A.; Costa, D.; Lopez-Bigas, N.; Schmitz, R.; Staudt, L. M.; Salaverria, I.; Lopez-Guillermo, A.; Campo, E.;.Referència: Leukemia 2018. -
Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia
Autors: Nadeu, F; Clot, G; Delgado, J; Martin-Garcia, D; Baumann, T; Salaverria, I; Bea, S; Pinyol, M; Jares, P; Navarro, A; Suarez-Cisneros, H; Aymerich, M; Rozman, M; Villamor, N; Colomer, D; Gonzalez, M; Alcoceba, M; Terol, MJ; Navarro, B; Colado, E; Payer, AR; Puente, XS; Lopez-Otin, C; Lopez-Guillermo, A; Enjuanes, A; Campo, E.Referència: Leukemia 2018.
Projectes destacats
-
Molecular Diagnosis, Prognosis, and Therapeutic Targets in Mantle Cell Lymphoma
Investigador/a principal: Elías Campo GüerriFinançador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); National Institut of Health (NHI)Codi: 1P01CA229100Durada: 01/09/2019 - 31/08/2023 -
Single-cell genomics to comprehensively understand healthy B-cell maturationand transformation to chronic lymphocytic leukemia (BCLL@las)
Investigador/a principal: E Campo, H Heyn, JI Martin-Subero, Gut. Ivo, Elias CampoFinançador: European Commission ; IDIBAPS (August Pi Sunyer Biomedical Research Institute), Barcelona, Spain. (Sede o evento)Codi: H2020-ERC-Sy_2018 (810287)Durada: 01/04/2019 - 31/03/2023 -
Functional and Clinical Impact of Genomics Analysis in CLL
Investigador/a principal: Elías Campo GüerriFinançador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); Instituto de Salud Carlos IIICodi: PMP15/00007Durada: 01/01/2016 - 30/09/2020 -
EUCANCan: a federated network of aligned and interoperable infrastructures for the homogeneous analysis, management and sharing of genomic oncology data for Personalised Medicine
Investigador/a principal: Elías Campo GüerriCodi: EUCANCANCERDurada: 01/01/2019 - 31/12/2022 -
La Medicina Personalitzada a Catalunya-Càncer (MedPerCan). Estudi pilot sobre l'impacte de l'anàlisi genòmica en la pressa de decisions en oncologia.
Investigador/a principal: Elías Campo GüerriCodi: SLT002/16/00374Durada: 01/01/2017 - 31/12/2019